HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

This study has been terminated.

Study NCT00228592 Information provided by Cubist Pharmaceuticals

First Received: September 27, 2005 Last Updated: February 12, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	August 2005
Estimated Primary Completion Date:	No date given